Clinical Trials Directory

Trials / Unknown

UnknownNCT05696834

Sclerotherapy and Bone Marrow Injection In Aneurysmal Bone Cyst

Sclerotherapy With Adjuvant Bone Marrow Injection In Management of Aneurysmal Bone Cyst

Status
Unknown
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
Al-Azhar University · Academic / Other
Sex
All
Age
1 Year
Healthy volunteers

Summary

Aneurysmal bone cysts (ABCs) are benign, locally destructive growing bone tumors, which were first described in 1942 by Jaffé and Lichtenstein (1). They are most often diagnosed in childhood and early adulthood. The literature reports that ABCs comprise 1-6% of all primary benign bone tumors (2). Most cases of ABCs (75-90%) are reported for patients younger than 20 years, with a slightly higher incidence for females (3). Most common localizations are the pelvis, the metaphysis of long bones and the spine, but ABCs can also affect any other localization(2). ABCs that are associated with a preexisting osseous lesion are defined as secondary ABCs. They represent approximately 30% of all ABCs (2). Secondary ABCs can occur, e.g., in cases of a giant cell tumor, chondroblastoma or telangiectatic osteosarcoma

Detailed description

The clinical symptoms of an ABC are usually accidently discovered or may consist of pain and swelling in the affected region and pathological fractures ( complete and incomplete ) can be observed occasionally. In conventional radiography a relatively well-defined osteolytic, expansile lesion with possible blowout of the periosteum and a soap-bubble appearance can be found (4). MRI scanning shows cystic formations with typical fluid-fluid levels due to blood sedimentation (7). Because of the possible rapid growth with local destruction, the literature describes cases of ABCs that mimic malignant bone tumors

Conditions

Interventions

TypeNameDescription
PROCEDURESclerotherapy With Adjuvant Bone Marrow Injection In Management of Aneurysmal Bone CystSclerotherapy With Adjuvant Bone Marrow Injection In Management of Aneurysmal Bone Cyst

Timeline

Start date
2023-03-01
Primary completion
2025-01-01
Completion
2025-12-01
First posted
2023-01-25
Last updated
2023-10-11

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05696834. Inclusion in this directory is not an endorsement.